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Perivascular adipose tissue (PVAT) is implicated in the pathophysiology of cardiovascular
disease, especially in obese individuals in which the quantity of renal and visceral PVAT is
markedly increased. The control of arterial tone by PVAT has emerged as a relatively
new field of experimental hypertension research. The discovery of this prototype of
vasoregulation has been mostly inferred from data obtained using wire myography.
Currently, there is a major discussion on distinguishing between biological vs. technical
replicates in biomedical studies, which resulted in numerous guidelines being published
on planning studies and publishing data by societies, journals, and associations.
Experimental study designs are determined depending on how the experimentator
distinguishes between biological vs. technical replicates. These definitions determine the
ultimate standards required for making submissions to certain journals. In this article,
we examine possible outcomes of different experimental study designs on PVAT control
of arterial tone using isolated arteries. Based on experimental data, we determine the
sample size and power of statistical analyses for such experiments. We discuss whether
n-values should correspond to the number of arterial rings and analyze the resulting
effects if those numbers are averaged to provide a single N-value per animal, or whether
the hierarchical statistical method represents an alternative for analyzing such kind of
data. Our analyses show that that the data (logEC50) from (+) PVAT to (–) PVAT arteries
are clustered. Intraclass correlation (ICC) was 31.4%. Moreover, it appeared that the
hierarchical approach was better than regular statistical tests as the analyses revealed
by a better goodness of fit (v2-2LL test). Based on our results, we propose to use at least
three independent arterial rings from each from three animals or at least seven arterial
rings from each from two animals for each group, i.e., (+) PVAT vs. (–) PVAT. Finally,
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we discuss a clinical situation where distinguishing between biological vs. technical
replicates can lead to absurd situations in clinical decision makings. We conclude that
discrimination between biological vs. technical replicates is helpful in experimental studies
but is difficult to implement in everyday’s clinical practice.
Keywords: adipocyte-derived relaxing factor (ADRF), perivascular adipose tissue (PVAT), biological replicates,
technical replicates, experimental study design, sample size, power of statistical analysis, hierarchical model
INTRODUCTION
The control of arterial tone by perivascular adipose tissue (PVAT)
has emerged as a relatively new field of vascular biology. After
a pioneering report by Soltis and Cassis (1), several subsequent
studies demonstrated a paracrine role for PVAT to produce
relaxation of arterial smooth muscle cells (VSMC). This led to
the discovery of a number of perivascular relaxation factors
(PVRFs) and their downstream K+ channel targets (2, 3) to
underlie arterial adipose-vascular coupling (4). The discovery
of this prototype of vasoregulation has been mostly inferred
from data obtained using wire myography on isolated arterial
rings (5–10). Renal PVAT alters also renal vascular function, in
particular because adipose tissue adjacent to renal blood vessels,
i.e., renal perivascular adipose tissue (RPVAT), contains a pool
of norepinephrine which can be released to alter renal vascular
function and could contribute to renovascular hypertension (11).
However, the further validation of novel concepts of preclinical
research and their transfer into clinical practice can face a
crucial obstacle observed in many other areas of scientific
practice: irreproducibility.
As such, reproducibility in biomedical research has become an
important topic of debate in the scientific community (12, 13).
Some data have indicated that only 20 % of studies published
even in prestige journals can be replicated (14). To address this
problem, the scientific community undertakes a lot of efforts
to improve the quality of animal studies, which resulted in
numerous guidelines on study planning, statistical evaluation,
and data presentation published by societies, journals, and
associations (15, 16). Some of these recommendations include
but are not limited to: blinding of experiments, randomized
allocation of animals to control and treatment groups, training
in and more appropriate use of statistics, use of appropriate
positive, and negative controls; determination of dose-response
relationships, and replication in different models, as reviewed
in (17–19).
Although recommendations toward the design of biomedical
studies are widespread and supported by pharmacological
societies (16), they still need consideration. One particularly
troubling aspect is distinguishing between biological vs. technical
replicates (20). Experimental study designs are determined
depending on how the experimentator distinguishes between
biological (considered “independent”) vs. technical replicates.
These definitions govern the ultimate standards required for
making submissions to certain journals. In addition, they
are expected to have an impact on decision-making by
scientific journals, funding agencies, authorities, and offices
of animal welfare. Generally, biological replicates are defined
as measurements of biologically distinct samples that show
biological variation (21). In contrast, technical replicates
are repeated measurements of the same sample that show
independentmeasures of the noise associated with the equipment
and the protocols. According to these definitions, it is not entirely
clear to which group isolated arteries belong to? This issue is
not as simple as it seems. For example, if we consider well-
known regional differences of vessel function and the recently
emphasized fact that even cells in a small segment of an artery
show large differences in behavior (22, 23). Is this a result of
independent samples? Moreover, calculations of sample size,
power and effect size are often missing (or at least not reported)
for measurements obtained using wire myography (one of the
“gold standard” methods in vascular research on arterial tone),
including studies with a focus on detecting anti-contractile effects
of PVAT.
In the past, studies in the field of PVAT research used standard
statistical tests to detect differences between data sets [e.g., (+)
PVAT vs. (–) PVAT]. Those tests (e.g., Mann-Whitney U or t-
test) are valid for independent samples. As a sample, one can
chose one piece of artery (n = number of arteries), independent
on whether they have been obtained from the same or different
animals. Alternatively, one can take n arteries from N animals,
calculate a mean for the n arteries obtained from one and the
same animal and treat the N animals as independent samples.
The last approach is less common in practice, because it decreases
the (apparent) ability to detect a difference, takesmore efforts and
finally could be considered as breaking one of the 3R principles
in animal research—Reduction (24).
In this article, we examine possible outcomes of different
experimental designs addressing as an example PVAT control
of arterial tone. Based on previously collected data, we also
determined the required sample size for appropriate statistical
analysis for such experiments. We discuss whether n-values
should correspond to the number of vessels and analyze the
resulting effects if those numbers are averaged to provide a
single value per animal, or whether the hierarchical statistical
method represents an alternative for analyzing such kind
of data.
METHODS
All experimental procedures were performed in accordance
with the German legislation on protection of animals. Animal
care followed American Physiological Society guidelines and
local authorities (Landesamt für Gesundheit und Soziales Berlin,
LAGeSo) approved all protocols. Mice (C57BL/6) were housed
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FIGURE 1 | Regulation of arterial tone by perivascular adipose tissue (PVAT). First order mesenteric arteries, perivascular fat and connective tissue were either intact
[(+) PVAT (A) or removed (–) PVAT (B)]. Schematic representation of using the average per animal (N, mice) approach (C) or single artery (n, arteries) approach (D) for
PVAT studies. Cumulative concentration-response relationships to phenylephrine (PE) with n representing the number of arteries or N representing the number of mice
(E) expressed as a percentage of KCl-induced contraction. Data are mean ± SE. (–) PVAT, n, arteries: n = 10; (+) PVAT, n, arteries: n = 10. (–) PVAT, N, mice: N = 10;
(+) PVAT, N, mice: N = 10. LogEC50 for PE between (–) PVAT and (+) PVAT groups (F) analyzed either as n, arteries (–) PVAT, n = 38; (+) PVAT, n = 39 or N, mice (–)
PVAT, N = 13; (+) PVAT, N = 13. Data are mean ±95% Cl. P < 0.05, ANOVA with post-hoc Tukey test N, mice (–) PVAT vs. N, mice (+) PVAT and n, arteries (–) PVAT
vs. n, arteries (+) PVAT.
in individually ventilated cages under standardized conditions
with an artificial 12-h dark–light cycle with free access to water
and food. Wire Myography on first order mesenteric arteries
was performed as previously described (25, 26). First order
mesenteric arteries were dissected into 2mm rings whereby
perivascular fat and connective tissue were either intact [(+)
PVAT (Figure 1A) or removed (–) PVAT (Figure 1B)] without
damaging the adventitia. The symbol n represents the number
of independent arteries tested (e.g., n = 10: artery 1, 2,
3, 4, 5, 6, 7, 9, 10). Data from multiple rings from the
same animal were averaged and treated as a single N [e.g.,
N = 3: (artery 1, 2, 3), (artery 4, 5, 6), (artery 7, 8, 9)].
Quantile-quantile (q-q) plot and a Shapiro-Wilk test were used
to test the normality of the data distribution. For deeper analysis,
anaconda 4.4.0 was used, including the following software:
python v3.6.1, matplotlib v2.0.2, numpy v1.13.1, pandas v0.20.3,
and statsmodels v0.8.0. Concentration-response fitting and EC50
calculation were performed using scipy.optimization.curve_fit
routine assuming Log-logistic 4-parameter function curve,
independently for each artery/animal. Effect size and sample size
calculations on EC50 values for a two-sided t-test were performed
using G∗ power software v3.1.9.3 (27). Statistical significance was
determined by two-tailed t-test or ANOVA with the post-hoc
Tukey test. For the calculations based on hierarchical analysis we
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used RStudio v1.1.383 and the R-script as previously described
(28). v2 test of change in −2 Log Likelihood (v2-2LL) was used
for the comparison of the hierarchical model vs. regularly used
statistical tests (29, 30). Effective sample size was calculated as
follows: forN animals, each with n arteries, and ICC representing
intraclass correlation.
Effective Sample Size =
N × n
1+ (n− 1)× ICC
RESULTS
Replicate Number n (Single Artery) vs. N
(Averaged per Animal)
First, we determined whether using N (averaged per animal) as
shown in Figure 1C vs. n (single artery) as shown in Figure 1D
provides advantages for detecting the anti-contractile effect of
PVAT using wire myography. For that reason, from a total data
set of 13 mice we randomly assigned similar numbers of arteries
(n = 10) and animals (N = 10). There were totally 10 arteries
(isolated from 3 mice), that were treated as independent samples;
or totally 38 arteries isolated from 10 mice, whereas the data were
averaged per animal and treated as independent sample N. We
found that both methods gave similar results, as can be seen in
the graphical analysis (Figure 1E).
In a detailed analysis, we evaluated the LogEC550 values
calculated either based on the n (single arteries) or the N
(averaged per animal) approach (Figure 1F). The number of
arteries collected from one animal ranged from two to five with a
mean value of 3 in both the (+) PVAT and (–) PVAT groups. The
LogEC50 95% CI for PE were−6.02 to−6.26 and−6.02 to−6.36
for the (–) PVAT group treated as single arteries or averaged per
animal, respectively; and −5.20 to −5.36 and −5.19 to −5.43 for
the (+) PVAT group treated as single arteries or averaged per
animal, respectively.
Two-Level Hierarchical Model for Detecting
the Anti-contractile Effect of PVAT
To evaluate clustering of our data, we estimated the intraclass
correlation (ICC) also known as the degree of clustering. ICC
quantifies the magnitude of clustering. The ICC was 31.4 %. The
hierarchical model resulted in a better fit (v2 test of change in
−2 Log Likelihood; see also methods) than the regularly used
method [single artery (n) or average per animal (N) approach]
for data analysis, although both methods resulted in successfully
detecting the difference between the (+) PVAT and (–) PVAT
groups (Table 1).
Required Sample Size in PVAT Studies
Next, we calculated the effect size (Cohen’s d) of the difference
between the PE concentration response relationships of vessels
with and without PVAT (based on EC50), i.e., the anti-contractile
effect of PVAT. Using the obtained effect size, we also estimated
the minimal sample size required for detecting the PVAT effect
with a power of 0.9 (1—type II error or beta) at different levels
of type I error or alpha (p = 0.05, p = 0.01, p = 0.001). Using
the hierarchical approach as previously described (28), we also
calculated the effective sample size for this experimental design.
The ICC can be used to estimate the effective sample size that is
neither n nor N. If the ICC is low, meaning each artery’s behavior
is independent of the animal from which the artery was isolated,
effective sample size approximates:
Effective Sample Size =
N × n
1+ (n− 1)× ICC
If the ICC is high, meaning behavior of arteries from a single
animal is identical, effective sample size approaches N. The
results show that for detecting PVAT-induced relaxation at p
= 0.05 using the hierarchical approach, the effective sample
size is equal to 6. The data are summarized in Figure 2
and Table 2.
DISCUSSION
Whilst in the past many important discoveries in medicine and
biology have been made without profound statistical analysis
(31), it is remarkable that nowadays the effect size seems to be in
focus of interest to contribute to major a key role in discoveries.
In contrast to basic research, size effect in clinical trials is
typically small implicating that thousands of participants are
often needed to be included in order to make reliable conclusions
(32). Of note, the effect size for PVAT-induced relaxation can
be classified as relatively large (33). Based on this effect size,
relatively small numbers of experiments are expected to be
needed to be performed in order to detect the anti-contractile
effect of PVAT (Table 2). However, there remains a fundamental
question, which needs to be considered: What is the most
appropriate strategy to design and analyze studies focused on
PVAT function in myography experiments on isolated arteries?
In other words, what is the independent sample criterion?
According to Blainey et al., one strategy is that organs from
sacrificed animals can be viewed as biological replicates (21).
However, it is not possible to view all arteries in an organism as a
single organ. Large caliber vessels differ from small caliber vessels.
Cerebral arteries differ from skeletal muscle or renal arteries in
the organism. In particular, cerebral arteries cannot exhibit an
anti-contractile effect of PVAT because PVAT does not surround
brain vessels, and thus, they have different mechanisms of arterial
tone regulation.
Biological variation, however, is also defined as variation
between organisms. In the past, researches used two different
approaches for analyzing data in PVAT studies. First, a
more conservative approach also known as the average per
animal approach was employed. According to this strategy,
all measurements—data points—obtained from a certain
intervention from several similar objects (e.g., several pieces
of a mesenteric artery) of one animal are averaged per animal
and treated as a single (N) data point, as shown on Figure 1C.
It is obvious that this approach requires relatively large
numbers of animals to test biological hypotheses. Treating
samples as N (per animal) reduces the standard deviation
(SD) and thus standard error of the mean (SEM) in wire
myography experiments compared to the single artery approach
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TABLE 1 | Analysis of the α1-receptor mediated contraction of (+) PVAT and (–) PVAT arterial rings using regular (N or n approach) and hierarchical statistical approaches.
Parameter Clustering of data (ICC), % Regular method Two-level hierarchy Comparison of goodness of fit (regular vs.
hierarchical)
Standard error P-value Standard error P-value
PE LogEC50 31.4 0.068 <0.05 0.087 <0.05 0.0094
The independent t-test represents the regular approach to compare contraction of (+) PVAT and (–) PVAT arterial rings. The clustering of the data was quantified by the intraclass
correlation coefficient (ICC). Comparison of goodness of fit was performed by the v2-2LL test.
(Figures 1E,F). As a result, the effect size (Cohen’s d) of the
difference of EC50 between (–) PVAT and (+) PVAT using
the average per animal approach is larger than with single
artery approach (details see below). Although the average per
animal approach results in relatively small sample sizes required
to detect the anti-contractile effect of PVAT (Table 2), the
number of experiments to be performed (number of vessels
studied) is relatively high. In fact, instead of using nine arteries
from one or two mice we would need to use seven mice to
detect the same difference (Table 2). Therefore, the average per
animal approach might come into conflict with one of the most
important foundations of the 3Rs principle of animal research—
Reduction (24) without revealing a different conclusion
(Figures 1E,F). On the other hand, this strategy may decrease
the probability of false positive or negative findings due to a “poor
preparation day.”
For a clinician, implementing the average per subject
approach to a patient with peripheral artery disease might
also be problematic. For example, in peripheral artery disease
(also called peripheral arterial disease) there is circulatory
problem in which narrowed arteries reduce critical blood flow,
e.g., to fingers or legs. If the clinical diagnoses shows critical
digital ischemia in one of the patient’s fingers what surgical
treatment (amputation) is appropriate? One might argue that
data from multiple arteries/cells from the same organism should
be averaged and treated as a single N, which would be the
inappropriate approach. The situation might be even more
complicated if two fingers show 100% stenosis (occlusion)
with gangrene and amputations are not considered as n =
2 independent surgeries, i.e., disaggregation of n = 2 arteries
but rather aggregation of N = 1 human. These examples
demonstrate how essential it is to distinguish between biological
(sometimes called “independent”) vs. technical replicates in daily
clinical decision-making.
The second strategy is most commonly used in experimental
research on isolated arteries and is also called the single artery
approach. This method assumes the independency of each
data point n (artery) and views an artery as source of the
biological variation (Figure 1D). In this view, isolated mesenteric
arteries are considered as objects of the study. A current
scheme for conducting such experiments is shown in Figure 3A.
Independently, 1-st order branches of mesenteric arteries should
be mounted on the wire myograph either with (+) PVAT or
without (–) PVAT. The scheme shown in Figures 3B,C also
could be used, although there is no data available neither
FIGURE 2 | Required sample size (different combinations of n and N) for
detecting the anti-contractile effect of PVAT using the hierarchical approach.
confirming nor disproving any meaningful physiological or
molecular-biological differences between these closely related
segments. In the scenario shown in Figure 3D, it is obvious that
the same segments are measured twice in the same chamber
and therefore should be viewed as a technical replicate. In
this case, data obtained from two measurements should be
averaged and treated as single n as it is recommended in
Curtis et al. (16).
It is also reasonable to argue that arteries isolated from the
same location in the circulatory system and from the same animal
will tend to behave similarly. For this situation, a special statistical
method has been developed, namely the hierarchical analysis
(29, 30). According to the two-level hierarchical model, data
points in a cluster (e.g., arteries from the same animal) tend
to be more similar to each other compared to data points in
other clusters (arteries from different animals). Recently, Sikkel
et al. successfully implemented this method for analyzing local
Ca2+ image data (Ca2+ sparks) in rats and concluded that Ca2+
sparks in rat cardiomyocytes are clustered (28). Therefore, the
assumption of the independency of each data point can lead
to the false conclusion about a difference (28). We tested this
approach and found that the hierarchical method is superior
to previously described average per animal or single artery
approaches for wire myography experiments in the absence or
presence of PVAT (Table 1). Indeed, we found that our data
(logEC50) are clustered (ICC 31.4%). Moreover, it appeared
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TABLE 2 | Required sample size for detecting the anti-contractile effect of PVAT.





































The effect size of the difference in the means (logEC50 for PE) between (–) PVAT and (+) PVAT arterial rings is expressed as Cohen’s d. Sample size was calculated based on the use of
the t-test. There were (–) PVAT, n = 38; (+) PVAT, n = 39 arteries; N = 13 mice in (–) PVAT and (+) PVAT groups. Sample size is given for *p = 0.05, **p = 0.01, ***p = 0.001. p—Type
I error or alpha. Power (1—Type II error or beta) is 0.9.
FIGURE 3 | Schematic representation of arterial rings obtained from
independent arteries dissected into 2mm long rings (A) or obtained from the
same arteries but prepared either with (+) PVAT or without (–) PVAT (B); or
obtained from the same artery and prepared in the same way [(–)PVAT, (+)
PVAT] (C); or technical replicate whereas the contractility of the same arterial
ring is measured twice and then averaged and treated as single n (D).
that the hierarchical approach was better than regular statistical
tests as the goodness of fit (v2-2LL test) for the hierarchical
approach was better. In addition, we calculated the effective
sample size for our PVAT studies (Table 2). For detecting a
PVAT-induced relaxation at p = 0.05 using the hierarchical
approach, the effective sample size was equal to 6. The results
suggest to use at least two arterial rings from each from four
animals for each group, i.e., (+) PVAT vs. (–) PVAT. Tominimize
the number of animals used, three arterial rings from each
from three animals or at least seven arterial rings from each
from two animals. This conclusion is based on an effective
sample size calculation for hierarchical analysis (Figure 2
and Table 2).
In summary, the experimental design of biomedical studies
is still a matter of intense ongoing discussions in renovascular
hypertension research. We examined three approaches to be
used in statistical analyses of data on PVAT control of arterial
tone. We conclude that neither the N (averaged per animal)
nor the n (single artery) approach provides an optimal statistical
tool for detecting the anti-contractile effect of PVAT using wire
myography. Both approaches have advantages and limitations as
discussed above. We conclude that hierarchical analysis of data
points seems to represent a reasonable approach to draw reliable
conclusions. The strength of our study lies within the statistical
treatment of the data and the way that we have considered
the variation in the biological assays. However, whether data
obtained in other vascular studies are also clustered remains
to be evaluated. For example, it needs to be studied whether
our approach can be implemented in video microscopic studies
using pressurized arteries or patch clamp studies on isolated
cells. However, due to technical reasons, it would be very
difficult to investigate PVAT effects in smaller pressurized vessels.
In this regard, the fat tissue surrounding vessels is expected
to perturb measurements of the inner and outer diameters
of the vessels. Nevertheless, our approach could be used for
the design of future studies using isolated arteries in wire-
myography experiments. In addition, we estimated the minimal
sample size required for detecting PVAT-induced relaxations
using the two-level hierarchical method, which can be used for
studies in the research on arterial adipose-vascular coupling and
in experimental hypertension research. Based on our results,
we propose that usage of at least three arterial rings each
from three mice is a reliable approach for wire myography to
study PVAT control of arterial tone. Furthermore, hierarchical
statistical analysis represents a better alternative statistical tool
for PVAT studies. In comparison to other research areas (e.g.,
clinical trials), this sample size seems to be relatively small. The
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explanation for this state of affairs is the relatively large size
effect of PVAT on arterial tone, which underscores and highlights
the pivotal role of PVAT in this relatively novel prototype
of vasoregulation.
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